Vertex Ventures invest US$5M in India-based fertility platform IVF Access

Bangalore-based fertility platform IVF Access has secured US$5 million Series A funding from Vertex Ventures SEA & India. With the investment, the VC firm’s Managing Partner, Ben Mathias, will be joining the board of IVF Access.

According to Your Story, IVF Access plans to use this funding to set up IVF clinics across India that provide assisted reproductive treatments, enabled by a proprietary IT platform.

Naresh Rao, Co-founder and CEO of IVF Access, shared, “When it comes to IVF, access is everything. IVF Access will increase the reach of such fertility treatments through a chain of clinics in India, where couples trying to conceive will have access to both technology and medical expertise.”

Indian building automation startup Hipla raises US$344K funding to accelerate its Singapore-based solutions ContaTrack.ai

Office automation software provider Hipla Technologies Pte Ltd has secured US$344,000 in funding from angel investors that the company claimed to be wealthy individuals from India and Singapore, including Mousumi Ghosh, the founder-director of Kolkata-based Future Medical and Research Trust, and Ang Hiap Chee, a Singapore-based early-stage investor in logistics companies.

According to VC Circle, the fresh funding the firm received will be used to support and accelerate Singapore-based Hipla Technologies’ new solution ContaTrack.ai, and to grow its products in the office automation space.

Also Read: Vertex Venture Holdings launches a US$290 million venture capital fund for technology firms in SEA

Sandeep Kaul, CEO at Hipla Technologies, explained that ContaTrack.ai provides AI-based computer vision to notify individuals when they are about to commit a safe-distancing breach.

Lucence launches Singapore’s Ministry of Health-approved clinical testing service

Singapore-based startup Lucence Diagnostics has attained approval from the Ministry of Health Singapore to launch SARS-CoV-2 RNA RT-PCR clinical testing service in an effort to support Singapore’s COVID-19 fights. The clinical testing service is also validated by the European QCMD (Quality Control of Molecular Diagnostics).

According to Biospectrum Asia, the SARS-CoV-2 RNA RT-PCR test is a diagnostic test intended to support COVID-19 diagnosis and disease monitoring by targeting specifically the SARS-CoV-2 RNA virus.

Lucence’s project has achieved full concordance with the QCMD 2020 Coronavirus Outbreak Preparedness (CVOP) EQA Pilot Scheme.

Singapore’s Antsomi launches software to help businesses transform into data-based companies

Based in Singapore, AI-enabled customer data platform Antsomi CDP 365 has launched an AI-driven marketing technology to assist businesses to transform into data-driven companies.

Antsomi was founded by former Malaysian Digital Association president and CtrlShift Malaysia head Serm Teck Choon and a Vietnamese technopreneur and the founder of digital company Ants Programmatic, Dinh Le Dat.

Antsomi CDP 365 seeks to address problems of overwhelming, confusing, and time-consuming customers’ data management, which is done by empowering companies to automate the consolidation of data to better understand their customers’ behaviour that results in action taken accordingly.

Also Read: To fulfill its goal to improve biopsy process, medtech startup Lucence raises US$20M in Series A

According to Malay Mail, the software’s AI engines unify all existing customer data from multiple sources, including mobile, web, social media, offline channels, customer relationship management, and more. The approach is expected to enable business operators, in industries such as retail, e-commerce, and the media, to use personalised individual customer profiles generated by this software to gain a better insight into their customers’ preferences.

–

e27 Pro membership will further empower you with insights, tools, and opportunities that help you solve the problems that hold you back. Begin your company’s journey to success here.

Image Credit: Olga Khabarova on Unsplash

The post News Roundup: Vertex Ventures invest US$5M in India-based fertility platform IVF Access appeared first on e27.